Cardiovascular Health BenefitsStudies suggest CLA may help reduce triglycerides, total cholesterol, and LDL cholesterol, supporting heart health
Sodiumglucose cotransporter-2 (SGLT2) inhibitors exert well-established cardioprotective and renoprotective effects, including improvements in cardiac cell metabolism and endothelial function and reductions in myocardial fibrosis
doi: 10.1038/nm1682
In this study, participants taking orforglipron experienced an average A1C reduction of 2.1% and an average weight loss of 10.1 kilograms at 26 weeks, which was significantly greater than those in the placebo and dulaglutide groups
This article does not assert that the four components produce additive, synergistic, or interacting effects when combined
Karnaukhova E, Krupnikova SS, Rajabi M, Alayash AI